Publication: IDENTIFICATION OF NOVEL BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC AUTOIMMUNE DISEASES THROUGH NEXT GENERATION PROTEOMICS
Loading...
Identifiers
Date
2022-06-01
Authors
Lopez-Pedrera, C.
Munoz-Barrera, L.
Escudero Contreras, A.
Aguirre-Zamorano, M. A.
Ortiz Buitrago, P.
Lopez-Medina, C.
Calvo Gutierrez, J.
Ortega Castro, R.
Pilar, F. U.
Sanchez-Pareja, I.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
BMJ Group
Metrics
Export
Abstract
Background: Systemic autoimmune diseases such as Rheumatoid Arthritis
(RA) and Systemic Lupus Erythematosus (SLE) are characterised by aberrant
autoimmune and inflammatory processes, which are directly associated with the development and progression of these disorders. Novel biomarkers associated with the severity of these diseases are needed to better characterise and monitor their progression as well as to develop new and more effective therapeutic strategies.
Description
MeSH Terms
Disruptive technology
Gene ontology
Proteomics
Antibodies
Biomarkers
Gene ontology
Proteomics
Antibodies
Biomarkers
DeCS Terms
Anticuerpos
Biomarcadores
Ontología de genes
Proteómica
Tecnología disruptiva
Biomarcadores
Ontología de genes
Proteómica
Tecnología disruptiva
CIE Terms
Keywords
Arthritis, rheumatoid, Lupus erythematosus, systemic, Reverse transcriptase polymerase chain reaction, Correlation of data
Citation
Lopez-Pedrera C, Muñoz-Barrera L, Contreras AE, Aguirre-Zamorano MÁ, Buitrago PO, López-Medina C, et al. POS0058 IDENTIFICATION OF NOVEL BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC AUTOIMMUNE DISEASES THROUGH NEXT GENERATION PROTEOMICS. Annals Of The Rheumatic Diseases [Internet]. 23 de mayo de 2022;81(Suppl 1):245.2-245